The Latin America, Middle East and Africa Medical Device Reprocessing Market would witness market growth of 16.3% CAGR during the forecast period (2022-2028).
A medical device can be safely used more than once in the same patient or in several patients if the reprocessing labeling instructions are carefully and appropriately following every use of the device. To preserve patient safety, reusable medical equipment must be properly reprocessed. Several types of reusable medical devices may retain blood, tissue, and other biological waste (dirt) if they are not properly cleaned in between patient uses.
Health care-Associated Infections may result from bacteria surviving the subsequent disinfection or sterilizing procedure as a result of this debris. Other negative patient consequences from insufficient reprocessing include tissue irritation from leftover reprocessing components, such as chemical disinfectants. However, because of the significant number of these devices in use, the risk of contracting such infections from one that was improperly reprocessed is rather low.
Cardiovascular disorders, such as coronary heart disease and stroke, are becoming more prevalent in South Africa. According to the National Library of Medicine, in South Africa, CHD, stroke, and the high mortality rates related to HIV and tuberculosis are among the top 10 main causes of death. Every hour, it is estimated that five people have a stroke, ten have a heart attack, and ten of them pass away. Although statistics on CHD and stroke mortality are available, there is little information on the incidence and prevalence of these illnesses nationally by gender and population category in South Africa.
The Brazil market dominated the LAMEA Medical Device Reprocessing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $71.4 million by 2028. The Argentina market is experiencing a CAGR of 16.9% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 16% during (2022 - 2028).
Based on Type, the market is segmented into Reprocessing Support & Services and Reprocessed Medical Devices. Based on Device Category, the market is segmented into Critical Devices, Semi- Critical Devices, and Non- Critical Devices. Based on Application, the market is segmented into Cardiology, Gynecology, General Surgery & Anesthesia, Gastroenterology, Arthroscopy & Orthopedic Surgery, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Medical Device Reprocessing Market is Predict to reach $4 Billion by 2028, at a CAGR of 13.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Johnson & Johnson, Medline Industries, Inc. (Centurion Medical Products Corporation), Medtronic PLC, Steris Healthcare, Arjo Group (ReNu Medical, Inc.), Cardinal Health, Inc. (Sustainable Technologies), Avante Health Solutions, Konoike Group, and Vanguard AG.
By Type
By Device Category
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
